ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,868,965	1,790,029	1,275,235	1,647,649	2,596,915	1,936,493
Market Cap Growth	-5.10%	40.37%	-22.60%	-36.55%	34.10%	248.32%
Enterprise Value	1,897,571	1,811,053	1,375,695	1,714,024	2,628,966	1,910,417
Last Close Price	90300.00	88900.00	67410.34	86388.45	136510.46	101442.21
PE Ratio	53.54	51.57	65.13	91.54	784.06	-
Forward PE	36.26	36.22	37.69	67.19	133.19	-
PS Ratio	6.27	6.54	4.47	6.61	15.68	15.60
PB Ratio	3.73	3.56	3.30	4.83	7.97	6.53
P/TBV Ratio	3.86	3.68	3.44	5.07	8.37	6.79
P/FCF Ratio	-	67.18	-	-	-	-
P/OCF Ratio	26.46	16.36	982.17	234.34	357.22	-
EV/Sales Ratio	6.37	6.62	4.83	6.88	15.87	15.39
EV/EBITDA Ratio	27.39	33.99	24.33	48.35	131.50	-
EV/EBIT Ratio	44.58	65.40	41.05	96.02	471.35	-
EV/FCF Ratio	-236.25	67.97	-	-	-	-
Debt / Equity Ratio	0.24	0.24	0.50	0.39	0.33	0.43
Debt / EBITDA Ratio	1.70	2.22	3.40	3.79	5.38	-
Debt / FCF Ratio	-	4.43	-	-	-	-
Asset Turnover	0.43	0.39	0.46	0.47	0.35	0.32
Inventory Turnover	1.18	1.46	1.54	1.72	1.75	2.45
Quick Ratio	0.99	1.43	2.53	0.82	3.00	10.07
Current Ratio	2.19	2.48	4.16	1.47	4.64	12.66
Return on Equity (ROE)	6.94%	7.30%	4.81%	5.25%	1.08%	-4.38%
Return on Assets (ROA)	3.83%	2.48%	3.36%	2.09%	0.74%	-2.99%
Return on Capital (ROIC)	4.44%	2.88%	3.97%	2.45%	0.81%	-3.17%
Return on Capital Employed (ROCE)	7.30%	4.70%	5.70%	4.60%	1.30%	-
Earnings Yield	1.82%	1.94%	1.54%	1.09%	0.13%	-0.63%
FCF Yield	-0.43%	1.49%	-3.29%	-3.24%	-1.71%	-1.96%
Dividend Yield	0.56%	0.56%	-	-	-	-
Payout Ratio	29.69%	27.09%	48.03%	52.25%	-	-
Buyback Yield / Dilution	-6.72%	-3.70%	-	-0.77%	-0.05%	-
Total Shareholder Return	-6.15%	-3.13%	-	-0.77%	-0.05%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.